Thank you! 

We look forward to seeing you in-person on July 23 from 9:30am-4pm (eastern) for the Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population hybrid public meeting. We have also received your request to provide public comment. Our goal is to ensure a variety of perspectives are shared; therefore, we will allocate speaking slots across stakeholder groups. Notifications will be made during the week of July 14.